ARCHIVES

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

This article is from The Cancer Letter archive.

Vol. 32 No. 43 | December 1, 2006

Download PDF Visit The Full Archive

Related Articles

Novel Four Drug Combination Safe For Lung Cancer Therapy

November 28, 2008

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

NCI Plans Briefing Oct. 8 In St. Louis for SPORE Applicants

August 23, 1991

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987

In Brief: Robert Cooper, Regional Cancer Center Director, Dead At 59; NCI Critic Epstein Invited to NCAB

April 3, 1992

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011